{"database": "openregs", "table": "documents", "rows": [["DEA-2021-0002-0001", "DEA", "DEA-2021-0002", "Schedules of Controlled Substances: Exempt Anabolic Steroid Products", "Rule", null, "2020-12-16T05:00:00Z", 2020, 12, "2020-12-16T05:00:00Z", "2021-02-17T04:59:59Z", "2021-01-06T18:55:28Z", "2020-25288", 0, 0, "09000064849a1ba4"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["DEA-2021-0002-0001"], "units": {}, "query_ms": 0.35315193235874176, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}